HAOHAI BIOTEC (06826): No A-Share Buybacks Implemented in July

Stock News
08/01

HAOHAI BIOTEC (06826) announced that the company did not implement any A-share buybacks in July 2025. As of July 31, 2025, the company has cumulatively repurchased 1.8324 million A-shares through centralized competitive trading, representing 0.79% of the company's total share capital of 233 million shares. The highest transaction price was 63.58 yuan per share, while the lowest was 49.25 yuan per share, with a total transaction value of 104 million yuan (excluding stamp tax, trading commissions, and other transaction costs).

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10